Abstract: Monitoring Electrical Systems with Multiple Ground Connection Points A method for monitoring an electrical system having multiple electrical ground connection points. The method comprises receiving reflectometry data that has been generated by performing time domain reflectometry on the electrical system, the time domain reflectometry being performed during a measurement time period. The method further comprises: determining a measured waveform from the reflectometry data, the measured waveform indicative of a measured state of the system during the measurement time period; obtaining a predetermined baseline waveform indicative of a baseline state of the system during a calibration time period; generating a difference waveform based on the measured waveform and the baseline waveform; and analysing the difference waveform to determine if there is a change of state in the electrical system between the calibration period and measurement period.

Abstract: Certain aspects of the present disclosure provide techniques for supporting multiple types of random access occasions. A method that may be performed by a user equipment (UE) includes receiving, from a base station (BS), an indication of at least two types of random access occasions (ROs) including a first RO type and a second RO type for communicating in a first coverage area of the BS as part of a random access process for the UE to establish a connection with the BS in the first coverage area. The method further includes transmitting, to the BS, a preamble on an RO of one of the first RO type or the second RO type, wherein a preamble format of the preamble is based on whether the RO is of the first RO type or the second RO type.

Abstract: Provided in the invention are a catalyst for preparing phosgene and a preparation method therefor, and a method for the preparation of phosgene and the comprehensive utilization of energy thereof. The preparation method comprises the following steps: 1) stirring and soaking activated carbon in a modifying solution, then adding dimethyltin dichloride and chromium oxide powders and carrying out a reaction, and then adding a nickel oxide fine powder and ultrasonically oscillating same to prepare a pre-modified activated carbon; 2) drying the pre-modified activated carbon; and 3) heating and calcinating the dried pre-modified activated carbon from step 2) to prepare the catalyst.

Abstract: Disclosed is a method for preparing a product for treating scald infection caused by Pseudomonas aeruginosa. The product includes a ferrous sulfate hydrogel, the scald is a deep second-degree scald or a third-degree scald, and a preparation process of the ferrous sulfate hydrogel includes: S1, obtaining a mixed solution by dissolving ferrous sulfate and vitamin C at a concentration ratio of 1:1 in sterile ultrapure water, heating the mixed solution to 50° C., and a concentration of the ferrous sulfate in the mixed solution being 2 mM, and S2, under a condition of heating, continuing to add sodium alginate powder whose mass constitutes 3.5% of a total mass of the mixed solution, stirring until the sodium alginate powder is dissolved and forming a stable colloid, and obtaining 2 mM of the ferrous sulfate hydrogel.

Abstract: Processes for producing reduced coenzyme Q10 (CoQ10) are provided. The processes may include preparing a reaction mixture, which includes oxidized CoQ10, a reductase, a supplement coenzyme, a coenzyme regeneration enzyme, and a substrate of the coenzyme regeneration enzyme, and providing a condition so that components of the reaction mixture react to produce the reduced CoQ10.

Abstract: A display panel includes a substrate, and a plurality of first pixel circuits, a plurality of first light-emitting devices and a plurality of first light-shielding portions that are located in a functional device setting region. The plurality of first light-emitting devices are disposed on a side of the plurality of first pixel circuits away from the substrate. A first light-emitting device includes a first electrode electrically connected to a first pixel circuit. The plurality of first light-shielding portions are arranged at intervals on a side of the plurality of first light-emitting devices away from the substrate. Each first light-shielding portion is provided with a first opening therein, and each first opening corresponds to a single first light-emitting device. An orthographic projection of a first portion of the first pixel circuit on the substrate is located within an orthographic projection of a first light-shielding portion on the substrate.

Abstract: A pharmaceutical combination comprising (i) a first component selected from an immune effector cell (e.g., a T cell and an NK cell) expressing a molecular switch-regulated CAR polypeptide, a nucleic acid molecule encoding the CAR polypeptide, a vector comprising the nucleic acid molecule, and any combination thereof; and (ii) a second component, which is an antibody that contains a P329G mutation and specifically binds to a B-cell maturation antigen (BCMA) protein. The present invention also relates to a kit comprising the pharmaceutical combination, and the use of the pharmaceutical combination in the treatment of BCMA-related diseases in a subject.

Abstract: Disclosed are techniques for positioning. A receiver measures a time of arrival (ToA) of a positioning reference signal (PRS) transmission of a first PRS sequence transmitted by a first transmitter, measures a ToA of a PRS transmission of a second PRS sequence transmitted by a second transmitter, and determines an observed time difference of arrival (OTDOA) as a difference between the ToA of the PRS transmission of the first PRS sequence and the ToA of the PRS transmission of the second PRS sequence, wherein the OTDOA is less than half a maximum differential delay expected between the PRS transmission of the first PRS sequence and the PRS transmission of the second PRS sequence, and wherein a repetition duration of the first PRS sequence and the second PRS sequence is greater than 10 milliseconds (ms) and at least twice the maximum differential delay.

Abstract: A method of interfacing a discrete digital workshop information system is provided, where the information system includes mutual integration among product lifecycle management (PLM), enterprise resource planning (ERP), a manufacturing execution system (MES), an energy management system (EMS), and a warehouse management system (WMS) of a finished product. A method of interfacing based on a data dictionary fusing different function datasets is proposed to solve the problems of a current discrete industry information system, such as single in function, a small amount of integrated information, a large number of “information islands” existing, incapable of achieving full-process informatization management and control, difficulty in product quality tracing and the like. By the method, it is possible to realize flexible production in a discrete manufacturing industry, precise management and control of a production process, significant improvement in product quality and significant reduction in operating costs.

Abstract: Provided is an information system and an information collection method that are capable of acquiring desired site data while preventing an increase in cost. A link logic definition unit 17 holds a link logic that is definition information defining a correspondence relation between an item value of the site data and a reference value that is an external value of transaction data used for acquiring the item value. A link logic data acquisition unit 18 acquires the item value of the site data by using the link logic.

Abstract: Provided are an antibody having an improved affinity for specifically binding to BCMA, an antibody further comprising a P329G mutation, and a conjugate, a fusion, a bispecific antibody or a pharmaceutical composition comprising the antibody. In addition, further provided are a nucleic acid encoding the antibody, a host cell comprising the nucleic acid, and a method for preparing the antibody. The present invention also relates to the therapeutic and diagnostic use of the antibody binding to BCMA.

Abstract: The present disclosure provides a method, apparatus, medium and device for extracting a river drying-up region and frequency, and belongs to the technical field of remote sensing. The method for extracting a river drying-up region and frequency can be applied to efficiently acquiring river drying-up information for a long time within the large spatial region. With the inverse normalized difference water index (iNDWI) and the maximum value composite (MVC) method for the remote sensing images, the present disclosure omits the troublesome step of separately extracting a river range for each image in the conventional method. In addition, the present disclosure quickly obtains the drying-up frequency by counting the total number of available images and the number of non-water images at the same pixel position, and yields a greater efficiency for extracting the river drying-up region and frequency.

Abstract: The present invention provides a mono-p-toluenesulfonate of (S)-(2-((5-chloro-2-((7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)amino)pyrimidin-4-yl)amino)-5-(methoxymethyl)phenyl)dimethyl phosphine oxide, and a hydrate and a crystal form thereof. The crystal form of p-toluenesulfonate has a good stability, is easy to process, and has a high solubility.

Abstract: The present disclosure provides a display device, a splicing display device, the display device includes: a display panel including a display region and a non-display region surrounding the display region, the non-display region including a bonding region; a backlight module disposed opposite to the display panel; a tape layer located on a peripheral side of the display panel and the backlight module, and an orthographic projection of the tape layer on a plane where the display device is located is not overlapped with an orthographic projection of the display panel on the plane where the display device is located.

Abstract: The application discloses a system and method for centrifugal intrusion of molten metal into porous media and then solidification positioning, including: test cups, used for placing test medium and molten metal intrusion; a rotor block, used for mounting the test cups, where one end of each test cup for placing the test medium is far away from the rotor block; a constant temperature oil bath preheating device, used for preheating the test cups and the rotor block; a centrifugal device, internally provided with the rotor block, used for performing a centrifugal operation on the test cups, where the test cups and the rotor block are installed inside the centrifugal device after being preheated; and an infrared heating and compression refrigerating device, arranged inside the centrifugal device, used for controlling a temperature of the test cups.

Abstract: In some embodiments, there is provided receiving, as an input to a first machine learning model, a plurality of data; learning, by the first machine learning model and based at least on the plurality of data, a latent space; generating, based on the plurality of data and the latent space, a proximity graph, wherein label knowledge from labeled data is diffused on a plurality of nodes of the proximity graph; filtering, by the proximity graph, the plurality of nodes to provide a top k most uncertain nodes, wherein the top k most uncertain nodes form a subset of a plurality of unlabeled data; and providing the subset of the plurality of unlabeled data to a second machine learning model comprised in an active learning process. Related system, methods, and articles of manufacture are also disclosed.

Abstract: Memory array structures might include a first conductive plate connected to memory cells of a first dummy block of memory cells and to memory cells of a second dummy block of memory cells on opposing sides of a first isolation region; a second conductive plate connected to memory cells of the first dummy block of memory cells and to memory cells of the second dummy block of memory cells on opposing sides of a second isolation region; first and second conductors selectively connected to a first global access line, and connected to the first conductive plate on opposing sides of the first isolation region; third and fourth conductors selectively connected to a second global access line, and connected to the second conductive plate on opposing sides of the second isolation region; and a fifth conductor connected to the third conductor and connected to the second conductor.

Abstract: The present invention generally relates to humanized antigen binding receptors capable of specific binding to an Fc domain comprising the amino acid mutation P329G according to EU numbering. The present invention also relates to T cells, transduced with an antigen binding receptor which is recruited by specifically binding to/interacting with the mutated Fc domain of therapeutic antibodies.

Abstract: A memory device includes a memory array configured as quad-level cell (QLC) memory and a control logic operatively coupled to the memory array. The control logic identifies a first two bits of particular pages of a QLC logical state. The control logic causes memory cells of the memory array to be coarse programmed with a threshold voltage distribution of a multi-level cell (MLC) logical state corresponding to the first two bits. The control logic reads the MLC logical state from the memory cells and a second two bits from a cache buffer to determine the QLC logical state. The control logic causes the memory cells to be further coarse programmed with a QLC threshold voltage distribution corresponding to the QLC logical state.

Abstract: The present invention provides a methionine adenosyltransferase 2A inhibitor. The structure of the methionine adenosyltransferase 2A inhibitor is as represented by general formula (I), and the definitions of substituents are as described in the specification. The present invention further provides a preparation method therefor. A compound represented by formula I provided by the present invention has significant methionine adenosyltransferase 2A inhibitory activity, and can be used in the treatment of diseases mediated by overexpression of methionine adenosyltransferase 2A.